US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 00:10:07 Source：Stellar Site news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Colin Jost left red
- Next：California congressman urges closer consultation with tribes on offshore wind
Related articles
- Bella Hadid goes braless in a thigh
- Xinhua Headlines: Rescuers Battle Cold, Aftershocks to Help NW China Earthquake Victims
- CCTF Listed as National 5A
- Archaeology Forum Held in Shanghai, Highlighting Climate Change, Social Sustainability
- Mohammad Mokhber: Who is Iran’s acting president?
- Palestinian death toll from Israeli attacks on Gaza rises to 32,226
- Xinhua Headlines: A Vibrant City on Ancient Silk Road — Kashgar in the Eyes of Foreign Tourists
- Population Survey to Monitor Development
- Demi Moore, 61, says full
- Volunteers for 6th CIIE Kick off On
- Grant Shapps vows he WILL find more planes for mass parachute drop to mark 80th anniversary of D
- Xiaohe Township in C China Makes Great Efforts to Promote Local Artists
- Xinhua Headlines: Rescuers Battle Cold, Aftershocks to Help NW China Earthquake Victims
- The Rural Girls Chasing Goals on Football Pitches
- Hilarious moment mother asks her Cocker Spaniel to help choose her lottery numbers
- Improved Logistics Spur Global Market in 'Double 11' Shopping Festival
- Traditional Skills Revitalized by Livestreaming in Remote Towns
- Chinese Armed Forces Deploy Multiple Rescue Forces in Response to Gansu Earthquake
- Bichette has 4 hits, Berríos snaps 4
- 10th National Constitution Day Marked in China
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Stellar Site news portal sitemap